Literature DB >> 25133427

FGF21 is an endocrine signal of protein restriction.

Thomas Laeger, Tara M Henagan, Diana C Albarado, Leanne M Redman, George A Bray, Robert C Noland, Heike Münzberg, Susan M Hutson, Thomas W Gettys, Michael W Schwartz, Christopher D Morrison.   

Abstract

Enhanced fibroblast growth factor 21 (FGF21) production and circulation has been linked to the metabolic adaptation to starvation. Here, we demonstrated that hepatic FGF21 expression is induced by dietary protein restriction, but not energy restriction. Circulating FGF21 was increased 10-fold in mice and rats fed a low-protein (LP) diet. In these animals, liver Fgf21 expression was increased within 24 hours of reduced protein intake. In humans, circulating FGF21 levels increased dramatically following 28 days on a LP diet. LP-induced increases in FGF21 were associated with increased phosphorylation of eukaryotic initiation factor 2α (eIF2α) in the liver, and both baseline and LP-induced serum FGF21 levels were reduced in mice lacking the eIF2α kinase general control nonderepressible 2 (GCN2). Finally, while protein restriction altered food intake, energy expenditure, and body weight gain in WT mice, FGF21-deficient animals did not exhibit these changes in response to a LP diet. These and other data demonstrate that reduced protein intake underlies the increase in circulating FGF21 in response to starvation and a ketogenic diet and that FGF21 is required for behavioral and metabolic responses to protein restriction. FGF21 therefore represents an endocrine signal of protein restriction, which acts to coordinate metabolism and growth during periods of reduced protein intake.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25133427      PMCID: PMC4153701          DOI: 10.1172/JCI74915

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  59 in total

Review 1.  Circulating fibroblast growth factors as metabolic regulators--a critical appraisal.

Authors:  Bo Angelin; Tobias E Larsson; Mats Rudling
Journal:  Cell Metab       Date:  2012-12-05       Impact factor: 27.287

2.  The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes.

Authors:  Gregory Gaich; Jenny Y Chien; Haoda Fu; Leonard C Glass; Mark A Deeg; William L Holland; Alexei Kharitonenkov; Thomas Bumol; Holger K Schilske; David E Moller
Journal:  Cell Metab       Date:  2013-09-03       Impact factor: 27.287

3.  Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population.

Authors:  Morgan E Levine; Jorge A Suarez; Sebastian Brandhorst; Priya Balasubramanian; Chia-Wei Cheng; Federica Madia; Luigi Fontana; Mario G Mirisola; Jaime Guevara-Aguirre; Junxiang Wan; Giuseppe Passarino; Brian K Kennedy; Min Wei; Pinchas Cohen; Eileen M Crimmins; Valter D Longo
Journal:  Cell Metab       Date:  2014-03-04       Impact factor: 27.287

4.  Metformin-induced inhibition of the mitochondrial respiratory chain increases FGF21 expression via ATF4 activation.

Authors:  Kook Hwan Kim; Yeon Taek Jeong; Seong Hun Kim; Hye Seung Jung; Kyong Soo Park; Hae-Youn Lee; Myung-Shik Lee
Journal:  Biochem Biophys Res Commun       Date:  2013-09-13       Impact factor: 3.575

5.  Fibroblast growth factor 21 is induced by endoplasmic reticulum stress.

Authors:  Frank G Schaap; Andreas E Kremer; Wouter H Lamers; Peter L M Jansen; Ingrid C Gaemers
Journal:  Biochimie       Date:  2012-11-02       Impact factor: 4.079

6.  Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice.

Authors:  João Paulo G Camporez; François R Jornayvaz; Max C Petersen; Dominik Pesta; Blas A Guigni; Julie Serr; Dongyan Zhang; Mario Kahn; Varman T Samuel; Michael J Jurczak; Gerald I Shulman
Journal:  Endocrinology       Date:  2013-06-13       Impact factor: 4.736

7.  Skeletal muscle mitochondrial uncoupling drives endocrine cross-talk through the induction of FGF21 as a myokine.

Authors:  Susanne Keipert; Mario Ost; Kornelia Johann; Francine Imber; Martin Jastroch; Evert M van Schothorst; Jaap Keijer; Susanne Klaus
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-12-17       Impact factor: 4.310

8.  Genome-wide meta-analysis of observational studies shows common genetic variants associated with macronutrient intake.

Authors:  Toshiko Tanaka; Julius S Ngwa; Frank J A van Rooij; M Carola Zillikens; Mary K Wojczynski; Alexis C Frazier-Wood; Denise K Houston; Stavroula Kanoni; Rozenn N Lemaitre; Jian'an Luan; Vera Mikkilä; Frida Renstrom; Emily Sonestedt; Jing Hua Zhao; Audrey Y Chu; Lu Qi; Daniel I Chasman; Marcia C de Oliveira Otto; Emily J Dhurandhar; Mary F Feitosa; Ingegerd Johansson; Kay-Tee Khaw; Kurt K Lohman; Ani Manichaikul; Nicola M McKeown; Dariush Mozaffarian; Andrew Singleton; Kathleen Stirrups; Jorma Viikari; Zheng Ye; Stefania Bandinelli; Inês Barroso; Panos Deloukas; Nita G Forouhi; Albert Hofman; Yongmei Liu; Leo-Pekka Lyytikäinen; Kari E North; Maria Dimitriou; Goran Hallmans; Mika Kähönen; Claudia Langenberg; Jose M Ordovas; André G Uitterlinden; Frank B Hu; Ioanna-Panagiota Kalafati; Olli Raitakari; Oscar H Franco; Andrew Johnson; Valur Emilsson; Jennifer A Schrack; Richard D Semba; David S Siscovick; Donna K Arnett; Ingrid B Borecki; Paul W Franks; Stephen B Kritchevsky; Terho Lehtimäki; Ruth J F Loos; Marju Orho-Melander; Jerome I Rotter; Nicholas J Wareham; Jacqueline C M Witteman; Luigi Ferrucci; George Dedoussis; L Adrienne Cupples; Jennifer A Nettleton
Journal:  Am J Clin Nutr       Date:  2013-05-01       Impact factor: 7.045

9.  FGF21 regulates metabolism and circadian behavior by acting on the nervous system.

Authors:  Angie L Bookout; Marleen H M de Groot; Bryn M Owen; Syann Lee; Laurent Gautron; Heather L Lawrence; Xunshan Ding; Joel K Elmquist; Joseph S Takahashi; David J Mangelsdorf; Steven A Kliewer
Journal:  Nat Med       Date:  2013-08-11       Impact factor: 53.440

10.  FGF21 contributes to neuroendocrine control of female reproduction.

Authors:  Bryn M Owen; Angie L Bookout; Xunshan Ding; Vicky Y Lin; Stan D Atkin; Laurent Gautron; Steven A Kliewer; David J Mangelsdorf
Journal:  Nat Med       Date:  2013-08-11       Impact factor: 53.440

View more
  224 in total

Review 1.  Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23.

Authors:  Chiara Degirolamo; Carlo Sabbà; Antonio Moschetta
Journal:  Nat Rev Drug Discov       Date:  2015-11-16       Impact factor: 84.694

Review 2.  Neural Control of Energy Expenditure.

Authors:  Heike Münzberg; Emily Qualls-Creekmore; Hans-Rudolf Berthoud; Christopher D Morrison; Sangho Yu
Journal:  Handb Exp Pharmacol       Date:  2016

3.  Metabolic Responses to Dietary Protein Restriction Require an Increase in FGF21 that Is Delayed by the Absence of GCN2.

Authors:  Thomas Laeger; Diana C Albarado; Susan J Burke; Lexus Trosclair; John W Hedgepeth; Hans-Rudolf Berthoud; Thomas W Gettys; J Jason Collier; Heike Münzberg; Christopher D Morrison
Journal:  Cell Rep       Date:  2016-07-07       Impact factor: 9.423

Review 4.  What Should I Eat and Why? The Environmental, Genetic, and Behavioral Determinants of Food Choice: Summary from a Pennington Scientific Symposium.

Authors:  Emily Qualls-Creekmore; Kara L Marlatt; Esther Aarts; Annadora Bruce-Keller; Tim S Church; Karine Clément; Jennifer O Fisher; Penny Gordon-Larsen; Christopher D Morrison; Helen E Raybould; Donna H Ryan; Philip R Schauer; Alan C Spector; Maartje S Spetter; Garret D Stuber; Hans-Rudolf Berthoud; Eric Ravussin
Journal:  Obesity (Silver Spring)       Date:  2020-06-10       Impact factor: 5.002

Review 5.  New insights into the mechanisms of the ketogenic diet.

Authors:  Detlev Boison
Journal:  Curr Opin Neurol       Date:  2017-04       Impact factor: 5.710

Review 6.  Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis.

Authors:  Lucas D BonDurant; Matthew J Potthoff
Journal:  Annu Rev Nutr       Date:  2018-05-04       Impact factor: 11.848

7.  GCN2 is required to increase fibroblast growth factor 21 and maintain hepatic triglyceride homeostasis during asparaginase treatment.

Authors:  Gabriel J Wilson; Brittany A Lennox; Pengxiang She; Emily T Mirek; Rana J T Al Baghdadi; Michael E Fusakio; Joseph L Dixon; Gregory C Henderson; Ronald C Wek; Tracy G Anthony
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-12-09       Impact factor: 4.310

Review 8.  Metabolic Factors Determining the Susceptibility to Weight Gain: Current Evidence.

Authors:  Tim Hollstein; Paolo Piaggi
Journal:  Curr Obes Rep       Date:  2020-06

9.  Liquid Sucrose Consumption Promotes Obesity and Impairs Glucose Tolerance Without Altering Circulating Insulin Levels.

Authors:  Susan J Burke; Heidi M Batdorf; Thomas M Martin; David H Burk; Robert C Noland; Christopher R Cooley; Michael D Karlstad; William D Johnson; J Jason Collier
Journal:  Obesity (Silver Spring)       Date:  2018-06-14       Impact factor: 5.002

10.  Higher protein intake is associated with increased risk for incident end-stage renal disease among blacks with diabetes in the Southern Community Cohort Study.

Authors:  R Malhotra; K L Cavanaugh; W J Blot; T A Ikizler; L Lipworth; E K Kabagambe
Journal:  Nutr Metab Cardiovasc Dis       Date:  2016-07-21       Impact factor: 4.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.